FcRn Blockade as a Targeted Therapeutic Strategy in Antibody-Mediated Autoimmune Diseases: A Focus on Warm Autoimmune Hemolytic Anemia. The gene discussed is FCGRT; the disease is autoimmune hemolytic anemia.